Aptose Receives $10 Million Facility Agreement Loan and Negotiates Future Collaboration Agreement with Hanmi for Tuspetinib Development
Aug 30, 2024
Contract Type
agreement
San DiegoBiotechnologyHealth CareMedicalTherapeuticsresearch
Description
Aptose Biosciences Inc. has received a $10 million loan through a Facility Agreement with Hanmi Pharmaceutical Co. Ltd. The loan is intended for the development of tuspetinib, a highly differentiated oral kinase inhibitor for the treatment of patients with acute myeloid leukemia (AML)
Company Information
Company
Aptose Biosciences
Location
12770 High Bluff Dr
San Diego, California, United States
About
Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address unmet clinical need in multiple hematologic malignancies.